177 related articles for article (PubMed ID: 33959953)
21. Transcriptomic rationale for synthetic lethality-targeting ERCC1 and CDKN1A in chronic myelomonocytic leukaemia.
Hurtado AM; Luengo-Gil G; Chen-Liang TH; Amaral F; Batta K; Palomo L; Lumbreras E; Przychodzen B; Caparros E; Amigo ML; Dıez-Campelo M; Zamora L; Salido Fierrez EJ; Maciejewski JP; Ortuño FJ; Vicente V; Del Canizo M; Sole F; Ferrer-Marin F; Wiseman DH; Jerez A
Br J Haematol; 2018 Aug; 182(3):373-383. PubMed ID: 29797327
[TBL] [Abstract][Full Text] [Related]
22. Impact of BCR/ABL gene expression on the proliferative rate of different subpopulations of haematopoietic cells in chronic myeloid leukaemia.
Primo D; Flores J; Quijano S; Sanchez ML; Sarasquete ME; del Pino-Montes J; Gaarder PI; Gonzalez M; Orfao A
Br J Haematol; 2006 Oct; 135(1):43-51. PubMed ID: 16939497
[TBL] [Abstract][Full Text] [Related]
23. Tumor microenvironment and clonal monocytes from chronic myelomonocytic leukemia induce a procoagulant climate.
Zannoni J; Mauz N; Seyve L; Meunier M; Pernet-Gallay K; Brault J; Jouzier C; Laurin D; Pezet M; Pernollet M; Cahn JY; Cognasse F; Polack B; Park S
Blood Adv; 2019 Jun; 3(12):1868-1880. PubMed ID: 31221660
[TBL] [Abstract][Full Text] [Related]
24. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
Ries C; Loher F; Zang C; Ismair MG; Petrides PE
Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
[TBL] [Abstract][Full Text] [Related]
25. Transcription of
Enukashvily NI; Belik LA; Semenova NY; Kostroma II; Motyko EV; Gritsaev SV; Bessmeltsev SS; Sidorkevich SV; Martynkevich IS
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239457
[TBL] [Abstract][Full Text] [Related]
26. Chronic myelomonocytic leukemia: The role of bone marrow biopsy immunohistology.
Orazi A; Chiu R; O'Malley DP; Czader M; Allen SL; An C; Vance GH
Mod Pathol; 2006 Dec; 19(12):1536-45. PubMed ID: 17041567
[TBL] [Abstract][Full Text] [Related]
27. Comparative Analysis of the Genetic Variants in Haematopoietic Stem/Progenitor and Mesenchymal Stem Cell Compartments in de novo Myelodysplastic Syndromes.
Bandara WMMS; Rathnayake AJIS; Neththikumara NF; Goonasekera HWW; Dissanayake VHW
Blood Cells Mol Dis; 2021 May; 88():102535. PubMed ID: 33461003
[TBL] [Abstract][Full Text] [Related]
28. Catalpol promotes the osteogenic differentiation of bone marrow mesenchymal stem cells via the Wnt/β-catenin pathway.
Zhu Y; Wang Y; Jia Y; Xu J; Chai Y
Stem Cell Res Ther; 2019 Jan; 10(1):37. PubMed ID: 30670092
[TBL] [Abstract][Full Text] [Related]
29. BCR-ABL1-positive microvesicles malignantly transform human bone marrow mesenchymal stem cells in vitro.
Fu FF; Zhu XJ; Wang HX; Zhang LM; Yuan GL; Chen ZC; Li QB
Acta Pharmacol Sin; 2017 Nov; 38(11):1475-1485. PubMed ID: 28836580
[TBL] [Abstract][Full Text] [Related]
30. Berberine promotes bone marrow-derived mesenchymal stem cells osteogenic differentiation via canonical Wnt/β-catenin signaling pathway.
Tao K; Xiao D; Weng J; Xiong A; Kang B; Zeng H
Toxicol Lett; 2016 Jan; 240(1):68-80. PubMed ID: 26478571
[TBL] [Abstract][Full Text] [Related]
31. Potential role of Notch signalling in CD34+ chronic myeloid leukaemia cells: cross-talk between Notch and BCR-ABL.
Aljedai A; Buckle AM; Hiwarkar P; Syed F
PLoS One; 2015; 10(4):e0123016. PubMed ID: 25849484
[TBL] [Abstract][Full Text] [Related]
32. Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.
Zhang X; Tu H; Yang Y; Jiang X; Hu X; Luo Q; Li J
J Biol Chem; 2019 Aug; 294(32):12167-12179. PubMed ID: 31235520
[TBL] [Abstract][Full Text] [Related]
33. Epigenetically Aberrant Stroma in MDS Propagates Disease via Wnt/β-Catenin Activation.
Bhagat TD; Chen S; Bartenstein M; Barlowe AT; Von Ahrens D; Choudhary GS; Tivnan P; Amin E; Marcondes AM; Sanders MA; Hoogenboezem RM; Kambhampati S; Ramachandra N; Mantzaris I; Sukrithan V; Laurence R; Lopez R; Bhagat P; Giricz O; Sohal D; Wickrema A; Yeung C; Gritsman K; Aplan P; Hochedlinger K; Yu Y; Pradhan K; Zhang J; Greally JM; Mukherjee S; Pellagatti A; Boultwood J; Will B; Steidl U; Raaijmakers MHGP; Deeg HJ; Kharas MG; Verma A
Cancer Res; 2017 Sep; 77(18):4846-4857. PubMed ID: 28684528
[TBL] [Abstract][Full Text] [Related]
34. Alteration of cellular and immune-related properties of bone marrow mesenchymal stem cells and macrophages by K562 chronic myeloid leukemia cell derived exosomes.
Jafarzadeh N; Safari Z; Pornour M; Amirizadeh N; Forouzandeh Moghadam M; Sadeghizadeh M
J Cell Physiol; 2019 Apr; 234(4):3697-3710. PubMed ID: 30317554
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the
Stoddart A; Wang J; Hu C; Fernald AA; Davis EM; Cheng JX; Le Beau MM
Blood; 2017 Jun; 129(22):2959-2970. PubMed ID: 28348148
[TBL] [Abstract][Full Text] [Related]
36. Role of WNT/β-catenin signaling in rejuvenating myogenic differentiation of aged mesenchymal stem cells from cardiac patients.
Brunt KR; Zhang Y; Mihic A; Li M; Li SH; Xue P; Zhang W; Basmaji S; Tsang K; Weisel RD; Yau TM; Li RK
Am J Pathol; 2012 Dec; 181(6):2067-78. PubMed ID: 23026201
[TBL] [Abstract][Full Text] [Related]
37. Mesenchymal stromal cells can repair radiation-induced pulmonary fibrosis via a DKK-1-mediated Wnt/β-catenin pathway.
Shao L; Zhang Y; Shi W; Ma L; Xu T; Chang P; Dong L
Cell Tissue Res; 2021 Apr; 384(1):87-97. PubMed ID: 33496879
[TBL] [Abstract][Full Text] [Related]
38. Zuogui Wan slowed senescence of bone marrow mesenchymal stem cells by suppressing Wnt/β-catenin signaling.
Kang X; Chen L; Yang S; Gong Z; Hu H; Zhang X; Liang C; Xu Y
J Ethnopharmacol; 2022 Aug; 294():115323. PubMed ID: 35483559
[TBL] [Abstract][Full Text] [Related]
39. Hypermethylation of Frizzled1 is associated with Wnt/β-catenin signaling inactivation in mesenchymal stem cells of patients with steroid-associated osteonecrosis.
Wu F; Jiao J; Liu F; Yang Y; Zhang S; Fang Z; Dai Z; Sun Z
Exp Mol Med; 2019 Feb; 51(2):1-9. PubMed ID: 30808872
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cells in patients with chronic myelogenous leukaemia or bi-phenotypic Ph+ acute leukaemia are not related to the leukaemic clone.
Wöhrer S; Rabitsch W; Shehata M; Kondo R; Esterbauer H; Streubel B; Sillaber C; Raderer M; Jaeger U; Zielinski C; Valent P
Anticancer Res; 2007; 27(6B):3837-41. PubMed ID: 18225540
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
